This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Korea Research Institute of Bioscience and Biotechnology, St Pharm Co., Ltd.. Active years: 2013-2015.
Company Filing History:
3 out of 334 
1 out of 19 
Years Active: 2013-2015
Title: Misun Won: Innovator in Cancer Treatment
Introduction
Misun Won is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compositions for cancer treatment. With a total of 3 patents to his name, his work is paving the way for novel therapeutic approaches.
Latest Patents
One of Misun Won's latest patents focuses on a pharmaceutical composition for treating cancer. This invention comprises deoxyribonucleic acids (DNA) that encode small interfering RNA (siRNA), which complementarily binds to the base sequence of the transcript of the FLJ25416 gene. The composition includes antisense RNA and short hairpin RNA (shRNA) that inhibit the expression of the FLJ25416 gene, which is known to be expressed in cancer cells. By targeting this gene, the composition aims to kill cancer cells, positioning it as a potential novel anti-cancer agent.
Career Highlights
Throughout his career, Misun Won has worked with esteemed organizations such as the Korea Research Institute of Bioscience and Biotechnology and St Pharm Co., Ltd. His experience in these institutions has allowed him to refine his expertise in biotechnology and pharmaceutical development.
Collaborations
Misun Won has collaborated with notable colleagues, including Kyung-Sook Chung and Kyeong-Eun Jung. These partnerships have contributed to the advancement of his research and innovations in cancer treatment.
Conclusion
Misun Won's innovative work in developing pharmaceutical compositions for cancer treatment highlights his significant role in the biotechnology field. His contributions are essential in the ongoing fight against cancer, showcasing the potential of targeted therapies.